Strs Ohio Oric Pharmaceuticals, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$8.04 - $16.03 $4,019 - $8,015	-500 Reduced 6.33%	7,400 $101,000
Q4 2023 Jan 30, 2024	BUY	$5.41 - $9.43 $42,739 - $74,497	7,900 New	7,900 $72,000
Q1 2021 Apr 23, 2021	SELL	$23.67 - $36.85 $127,818 - $198,990	-5,400 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$20.32 - $39.8 $65,024 - $127,359	3,200 Added 145.45%	5,400 $182,000
Q2 2020 Jul 23, 2020	BUY	$25.68 - $38.12 $56,496 - $83,864	2,200 New	2,200 $74,000

112

63.1M

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $406M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.